e-learning
resources
ERJ
2003
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats
Hampl V., Bibova J., Povysilova V., Herget J.
Source:
Eur Respir J 2003; 21: 862-865
Journal Issue:
May
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Hampl V., Bibova J., Povysilova V., Herget J.. Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats. Eur Respir J 2003; 21: 862-865
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Role of NO pathway, calcium and potassium channels in the peripheral pulmonary vascular tone in dogs
Source: Eur Respir J 2001; 17: 20-26
Year: 2001
SUR1/Kir6.2 potassium channel a new actor involved in pulmonary arterial hypertension
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020
Molecular physiology of oxygen-sensitive potassium channels
Source: Eur Respir J 2001; 18: 221-227
Year: 2001
Potassium channels in pulmonary arterial hypertension
Source: Eur Respir J 2015; 46: 1167-1177
Year: 2015
Prediction of effects of calcium channel blockers (CCB) on hypoxic pulmonary hypertension (HPH) due to COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 268s
Year: 2003
The pathophysiological roles of a voltage-gated potassium channel Kv1.5 in toluene diisocyanate-induced asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 29s
Year: 2002
Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma
Source: Eur Respir J 2011; 37: 342
Year: 2011
Stable prostacyclin analogues treprostinil and iloprost activates K
Ca
and two-pore domain TASK-1 channels in human pulmonary artery smooth muscle cells
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008
Effects of duramycin on cardiac voltage-gated ion channels
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009
Loss of response to calcium channel blockers after long-term follow up in idiopathic pulmonary arterial hypertension
Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension
Year: 2020
Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension
Source: Eur Respir J 2016; 48: 1127-1136
Year: 2016
KCNK3 channel inactivation leads to pulmonary vascular alterations in rat
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018
Ca
2+
-activated K
+
channel openers cause epithelium and endothelium-dependent relaxation in pulmonary tissue
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008
Effect of the KCa3.1 k+ channels blocker triarylmethane-34 in a murine model of chronic asthma
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009
Channelopathies in bronchiectasis
Source: Eur Respir Mon 2011; 52: 150-162
Year: 2011
Dehydroepiandrosterone reverses chronic hypoxia/reoxygenation-induced right ventricular dysfunction in rats
Source: Eur Respir J 2012; 40: 1420-1429
Year: 2012
Role of prostaglandins, nitric oxide and potassium channel in the blunting of hypoxic pulmonary vasoconstriction in the high altitude adaptive animal – Pika
Source: Eur Respir J 2005; 26: Suppl. 49, 352s
Year: 2005
The potential effects of pregnancy in a patient with idiopathic pulmonary arterial hypertension responding to calcium channel blockade
Source: Eur Respir J, 50 (6) 1701141; 10.1183/13993003.01141-2017
Year: 2017
Anti-proliferating effect of iptakalim, a novel K
ATP
channel opener, in cultured rabbit pulmonary arterial smooth muscle cells
Source: Eur Respir J 2005; 26: Suppl. 49, 353s
Year: 2005
Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2009; 33: 1354-1360
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept